
Building Medical Supply Chain Resilience through a U.S. Manufacturing Reserve and Digital Stockpile
Summary
To prevent another medical supply chain breakdown like the one experienced during the COVID-19 pandemic, the Federal Government must create an emergency response plan to activate domestic, local medical supply manufacturing. A national network of small-to-mid-size manufacturers and prototyping labs — a U.S. Prototyping and Manufacturing Reserve — should be formalized and incentivized to act as first responders for emergency innovation and medical supply manufacturing needs.
To properly equip the Reserve, the Federal Government should build a comprehensive library of open source medical and emergency supply “blueprints” — a U.S. Digital Stockpile — that consists of manufacturing requirements to enable distributed local emergency production. Combined, these new national security resources will facilitate rapid local response to both regional disasters and international supply chain disruptions.
The U.S. is facing a shortage in both pilot-scale and manufacturing-scale biomanufacturing facilities that severely hinders product development and commercialization.
The space economy is enormous, but one of its biggest challenges is tiny: space debris.
The U.S. would need 65,000 miles of pipeline to achieve net-zero emissions by 2050. Here’s how the Biden Administration can expanding the use of low-emission, composite materials to support a net-zero vision.
Amino acids are essential but costly inputs for large-scale bioproduction. Federal funding can incentivize scalable production, cutting these costs in half.